Masakazu Abe

964 total citations
48 papers, 713 citations indexed

About

Masakazu Abe is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Masakazu Abe has authored 48 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 13 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Masakazu Abe's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Liver Disease and Transplantation (8 papers). Masakazu Abe is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Liver Disease and Transplantation (8 papers). Masakazu Abe collaborates with scholars based in Japan, Spain and South Korea. Masakazu Abe's co-authors include Hirohito Takeuchi, Yu Yoshimasu, Takao Itoi, Katsutoshi Sugimoto, Tetsuya Goto, Seiichi Saito, Alan Solomon, Makoto Takishita, Yoshitaka Kasai and Kentaro Sakamaki and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

Masakazu Abe

47 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masakazu Abe Japan 13 314 246 137 107 91 48 713
Hiroyuki Shimomura Japan 17 493 1.6× 500 2.0× 241 1.8× 90 0.8× 72 0.8× 58 1.1k
Shozo Miyake Japan 16 356 1.1× 437 1.8× 69 0.5× 67 0.6× 19 0.2× 38 643
Catherine Edwards-Smith Australia 7 391 1.2× 422 1.7× 83 0.6× 122 1.1× 24 0.3× 10 832
Lidija M. Petrovic United States 14 264 0.8× 375 1.5× 89 0.6× 103 1.0× 26 0.3× 27 700
Masafumi Naito Japan 17 859 2.7× 962 3.9× 111 0.8× 156 1.5× 88 1.0× 56 1.4k
Tsukasa Aihara Japan 15 156 0.5× 169 0.7× 329 2.4× 199 1.9× 66 0.7× 89 1.0k
Dimitra Bon Germany 16 296 0.9× 302 1.2× 142 1.0× 105 1.0× 89 1.0× 25 709
Vincent Leroy France 17 545 1.7× 636 2.6× 58 0.4× 112 1.0× 35 0.4× 41 945
Hamid Namini United States 11 455 1.4× 351 1.4× 154 1.1× 502 4.7× 24 0.3× 21 1.2k
Imen Sfar Tunisia 16 134 0.4× 110 0.4× 124 0.9× 84 0.8× 53 0.6× 80 628

Countries citing papers authored by Masakazu Abe

Since Specialization
Citations

This map shows the geographic impact of Masakazu Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masakazu Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masakazu Abe more than expected).

Fields of papers citing papers by Masakazu Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masakazu Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masakazu Abe. The network helps show where Masakazu Abe may publish in the future.

Co-authorship network of co-authors of Masakazu Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Masakazu Abe. A scholar is included among the top collaborators of Masakazu Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masakazu Abe. Masakazu Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wada, Takuya, Katsutoshi Sugimoto, Kentaro Sakamaki, et al.. (2023). Comparisons of Radiofrequency Ablation, Microwave Ablation, and Irreversible Electroporation by Using Propensity Score Analysis for Early Stage Hepatocellular Carcinoma. Cancers. 15(3). 732–732. 15 indexed citations
2.
Nagai, Kazumasa, Shuntaro Mukai, Masakazu Abe, et al.. (2023). Long-term outcomes after EUS-guided antegrade intervention for benign bilioenteric anastomotic stricture. Gastrointestinal Endoscopy. 99(1). 50–60. 2 indexed citations
3.
Furuichi, Yoshihiro, et al.. (2022). Discrimination between Portal Hypertensive Gastropathy and <i>Helicobacter pylori</i>-related Gastritis. Internal Medicine. 61(5). 601–603. 2 indexed citations
4.
Sugimoto, Katsutoshi, Dong Ho Lee, Jae Young Lee, et al.. (2021). Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study. Radiology. 301(3). 625–634. 33 indexed citations
5.
Sugimoto, Katsutoshi, Masakazu Abe, Hisashi Oshiro, et al.. (2021). The most appropriate region-of-interest position for attenuation coefficient measurement in the evaluation of liver steatosis. Journal of Medical Ultrasonics. 48(4). 615–621. 11 indexed citations
6.
Abe, Masakazu, Yoshihiro Furuichi, Hirohito Takeuchi, Yu Yoshimasu, & Takao Itoi. (2021). Prognostic and recurrence factors after endoscopic injection sclerotherapy for esophageal varices. Digestive Endoscopy. 34(2). 367–378. 5 indexed citations
7.
Sugimoto, Katsutoshi, Masakazu Abe, Yu Yoshimasu, et al.. (2020). Irreversible electroporation of hepatocellular carcinoma: the role of ultrasonography. ULTRASONOGRAPHY. 39(3). 229–237. 5 indexed citations
8.
Abe, Masakazu, et al.. (2020). A case of long-term survival after splenectomy for solitary splenic metastasis from gastric cancer. World Journal of Surgical Oncology. 18(1). 250–250. 2 indexed citations
9.
Sugimoto, Katsutoshi, Fuminori Moriyasu, Hisashi Oshiro, et al.. (2020). The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis. Radiology. 296(3). 532–540. 140 indexed citations
10.
Furuichi, Yoshihiro, Hirohito Takeuchi, Masakazu Abe, Yoshitaka Kasai, & Takao Itoi. (2019). 585 – Effect of Thrombopoietin Receptor Agonist is Higher Than that of Platelet Transfusion in Chronic Liver Disease with Thrombocytopenia –From Propensity Score Matching-. Gastroenterology. 156(6). S–113. 1 indexed citations
12.
Sugiura, Tsuyoshi, et al.. (2012). CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells. International Journal of Oncology. 41(6). 2021–2028. 18 indexed citations
13.
Matsumoto, Joe, et al.. (2009). Portal vein tumor thrombus from colorectal cancer with no definite metastatic nodules in liver parenchyma. Journal of Hepato-Biliary-Pancreatic Surgery. 16(5). 688–691. 17 indexed citations
14.
Abe, Masakazu, Hiroshi Ogawa, & A. Ayhan. (2008). The use of non‐three‐layer ultrasound in biopsy recommendation for premenopausal women. Acta Obstetricia Et Gynecologica Scandinavica. 87(11). 1155–1161.
15.
Takahashi, Miho, et al.. (2007). Regulation of c‐Met signaling by the tetraspanin KAI‐1/CD82 affects cancer cell migration. International Journal of Cancer. 121(9). 1919–1929. 53 indexed citations
16.
Nakamura, R., M. Ishiguro, A. Nakamura, et al.. (2005). Inflight Calibration of Asteroid Multiband Imaging Camera Onboard Hayabusa: Preliminary Results. LPI. 1602. 1 indexed citations
17.
Irisawa, Atsushi, Katsutoshi Obara, Yukio Sato, et al.. (2000). Adherence of Cyanoacrylate which Leaked from Gastric Varices to the Left Renal Vein During Endoscopic Injection Sclerotherapy: A Histopathologic Study. Endoscopy. 32(10). 804–806. 28 indexed citations
18.
Ikeda, Yoshio, et al.. (1983). Preventive and therapeutic effects of gliclazide on diabetic retinopathy: Comparison with glibenclamide treatment.. The Tohoku Journal of Experimental Medicine. 141(Suppl). 707–711. 7 indexed citations
19.
Isogai, Yukihide, et al.. (1979). The effects of Ticlopidine (DE-4160) on platelet function and hemorheological parameters. Blood & Vessel. 10(1). 145–148. 3 indexed citations
20.
KOTAKE, Yahito, et al.. (1968). Studies on the Xanthurenic Acid-Insulin Complex. The Journal of Biochemistry. 63(5). 578–581. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026